FISH analysis of 371 tissue samples that included benign prostatic hyperplasia (BPH), primary, locally recurrent, and metastatic PC showed no ERBB2 amplifications in any PC samples irrespective of disease stage [54]. Here, ERBB2 is linked to benign prostatic hyperplasia.